NASDAQ:COO 5 December 2025

Cooper Companies, Inc., the medical device group behind CooperVision contact lenses and CooperSurgical women’s health products, is back in the spotlight after a busy 24 hours of earnings, strategic moves and analyst reactions.

The Cooper Companies, Inc. just dropped a packed news day: fiscal Q4 2025 earnings, upbeat 2026 guidance, a formal strategic review, and a change in board leadership. Together, these announcements on 4 December 2025 jolted COO stock higher in extended trading and reshaped the investment narrative around this mid-cap medtech name. GlobeNewswire+2Reuters+2